Chemotherapy dose escalation: case unproven
LL Siu and IF Tannock
JCO Aug 1 1997: 2765–2768. [PDF]
	Randomized study of intensive MOPP-ABVD with or without low-dose total- nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study
	MA Weiner, B Leventhal, ML Brecher, RB Marcus, A Cantor, PW Gieser, JL Ternberg, FG Behm, MD Wharam, Jr, and AR Chauvenet
	JCO Aug 1 1997: 2769–2779. [Abstract] [PDF]
	Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group
	PA Dinndorf, VI Avramis, S Wiersma, MD Krailo, W Liu-Mares, NL Seibel, JK Sato, RB Mosher, JF Kelleher, and GH Reaman
	JCO Aug 1 1997: 2780–2785. [Abstract] [PDF]
	Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin- Frankfurt-Munster groups
	V Conter, M Schrappe, M Arico, A Reiter, C Rizzari, M Dordelmann, MG Valsecchi, M Zimmermann, WD Ludwig, G Basso, G Masera, and H Riehm
	JCO Aug 1 1997: 2786–2791. [Abstract] [PDF]
	Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital
	A Gajjar, RA Sanford, R Heideman, JJ Jenkins, A Walter, Y Li, JW Langston, M Muhlbauer, JM Boyett, and LE Kun
	JCO Aug 1 1997: 2792–2799. [Abstract] [PDF]
	Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer
	CT Quinn, JC Griener, T Bottiglieri, K Hyland, A Farrow, and BA Kamen
	JCO Aug 1 1997: 2800–2806. [Abstract] [PDF]
	Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
	NK Cheung, G Heller, BH Kushner, C Liu, and IY Cheung
	JCO Aug 1 1997: 2807–2817. [Abstract] [PDF]
	Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study
	R Glaser, K Rass, S Seiter, A Hauschild, E Christophers, and W Tilgen
	JCO Aug 1 1997: 2818–2825. [Abstract] [PDF]
	Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
	FA Jung, AC Buzaid, MI Ross, KV Woods, JJ Lee, M Albitar, and EA Grimm
	JCO Aug 1 1997: 2826–2831. [Abstract] [PDF]
	Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management
	MJ Heslin, JJ Lewis, E Nadler, E Newman, JM Woodruff, ES Casper, D Leung, and MF Brennan
	JCO Aug 1 1997: 2832–2839. [Abstract] [PDF]
	Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study
	A Gregor, P Drings, J Burghouts, PE Postmus, D Morgan, T Sahmoud, A Kirkpatrick, O Dalesio, and G Giaccone
	JCO Aug 1 1997: 2840–2849. [Abstract] [PDF]
	Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial
	SP Tannehill, MP Mehta, M Larson, B Storer, J Pellet, TJ Kinsella, and JH Schiller
	JCO Aug 1 1997: 2850–2857. [Abstract] [PDF]
	Immunocytochemical markers in stage I lung cancer: relevance to prognosis
	U Pastorino, S Andreola, E Tagliabue, F Pezzella, M Incarbone, G Sozzi, M Buyse, S Menard, M Pierotti, and F Rilke
	JCO Aug 1 1997: 2858–2865. [Abstract] [PDF]
	Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival
	F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, F Cardenal, N Vinolas, J Garcia del Muro, C Vadell, WP Mason, R Rosell, JB Posner, and FX Real
	JCO Aug 1 1997: 2866–2872. [Abstract] [PDF]
	Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience
	SD Merajver, BL Weber, R Cody, D Zhang, M Strawderman, KA Calzone, V LeClaire, A Levin, J Irani, M Halvie, D August, M Wicha, A Lichter, and LJ Pierce
	JCO Aug 1 1997: 2873–2881. [Abstract] [PDF]
	High-dose chemotherapy and stem-cell rescue in the treatment of high- risk breast cancer: prognostic indicators of progression-free and overall survival
	G Somlo, JH Doroshow, SJ Forman, T Odom-Maryon, J Lee, W Chow, V Hamasaki, L Leong, R Morgan, Jr, K Margolin, J Raschko, S Shibata, M Tetef, Y Yen, J Simpson, and A Molina
	JCO Aug 1 1997: 2882–2893. [Abstract] [PDF]
	HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas
	MF Press, L Bernstein, PA Thomas, LF Meisner, JY Zhou, Y Ma, G Hung, RA Robinson, C Harris, A El-Naggar, DJ Slamon, RN Phillips, JS Ross, SR Wolman, and KJ Flom
	JCO Aug 1 1997: 2894–2904. [Abstract] [PDF]
	Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma
	R Pazdur, E Diaz-Canton, WP Ballard, JE Bradof, S Graham, SG Arbuck, JL Abbruzzese, and R Winn
	JCO Aug 1 1997: 2905–2909. [Abstract] [PDF]
	Phase II trial of irinotecan in patients with metastatic colorectal carcinoma
	HC Pitot, DB Wender, MJ O'Connell, G Schroeder, RM Goldberg, J Rubin, JA Mailliard, JA Knost, C Ghosh, RJ Kirschling, R Levitt, and HE Windschitl
	JCO Aug 1 1997: 2910–2919. [Abstract] [PDF]
	Combined modality therapy for stage II and stage III pancreatic carcinoma
	AG Kamthan, JC Morris, J Dalton, JP Mandeli, MR Chesser, D Leben, A Cooperman, and HW Bruckner
	JCO Aug 1 1997: 2920–2927. [Abstract] [PDF]
	Bicalutamide for advanced prostate cancer: the natural versus treated history of disease
	HI Scher, C Liebertz, WK Kelly, M Mazumdar, C Brett, L Schwartz, G Kolvenbag, L Shapiro, and M Schwartz
	JCO Aug 1 1997: 2928–2938. [Abstract] [PDF]
	Effective chemotherapy for advanced CNS embryonal tumors in adults
	E Galanis, JC Buckner, PJ Schomberg, JE Hammack, C Raffel, and BW Scheithauer
	JCO Aug 1 1997: 2939–2944. [Abstract] [PDF]
	Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years
	Y Bastion, JY Blay, M Divine, P Brice, D Bordessoule, C Sebban, M Blanc, H Tilly, P Lederlin, E Deconinck, B Salles, C Dumontet, J Briere, and B Coiffier
	JCO Aug 1 1997: 2945–2953. [Abstract] [PDF]
	Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
	R Ohno, S Miyawaki, K Hatake, K Kuriyama, K Saito, A Kanamaru, T Kobayashi, Y Kodera, K Nishikawa, S Matsuda, O Yamada, E Omoto, H Takeyama, K Tsukuda, N Asou, M Tanimoto, H Shiozaki, M Tomonaga, T Masaoka, Y Miura, F Takaku, Y Ohashi, and K Motoyoshi
	JCO Aug 1 1997: 2954–2965. [Abstract] [PDF]
	Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy
	WS Lofters, JL Pater, B Zee, E Dempsey, D Walde, JP Moquin, K Wilson, P Hoskins, RM Guevin, S Verma, R Navari, JE Krook, J Hainsworth, M Palmer, and C Chin
	JCO Aug 1 1997: 2966–2973. [Abstract] [PDF]
	Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients
	N Ellison, CL Loprinzi, J Kugler, AK Hatfield, A Miser, JA Sloan, DB Wender, KM Rowland, R Molina, TL Cascino, AM Vukov, HS Dhaliwal, and C Ghosh
	JCO Aug 1 1997: 2974–2980. [Abstract] [PDF]
	Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors
	DM Savarese, C Hsieh, and FM Stewart
	JCO Aug 1 1997: 2981–2995. [Abstract] [PDF]
	Clinical practice guidelines for the treatment of unresectable non- small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology
	JCO Aug 1 1997: 2996–3018. [Abstract] [PDF]
CNS metastases: one's too many
A Lekos and MJ Glantz
JCO Aug 1 1997: 3019–3020. [PDF]
Comparing an apple to a fruit salad
N Spector, W Pulcheri, M Nucci, and A Maiolino
JCO Aug 1 1997: 3021–3022. [PDF]
Hodgkin's disease failures: incorporating radiotherapy and high-dose treatment
HM Prince, A Wirth, and M Wolf
JCO Aug 1 1997: 3022–3023. [PDF]
Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast cancer
SD Costa, G von Minckwitz, JF Gauwerky, M Kaufmann, and IJ Diel
JCO Aug 1 1997: 3023–3024. [PDF]
Can prophylactic CNS radiotherapy be omitted in high-risk childhood acute lymphoblastic leukemia?
W Balwierz, J Armata, S Skoczen, and W Strojny
JCO Aug 1 1997: 3024–3026. [PDF]
Cutaneous melanoma, staging system
L Nathanson
JCO Aug 1 1997: 3026. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.